IGC Pharma introduces AI platform to predict Alzheimer's risk - AuntMinnie
Yesterday • Google News
India Globalization Capital Inc (IGC)
US$ 0.3736-1.42%
Price Chart
Key Statistics
Market Cap
$ 28.49M
P/E Ratio
0.00
Revenue (TTM)
$ 1.27M
Volume
241.64K
52W High
$ 0.50
52W Low
$ 0.25
Dividend Yield
0.00%
Beta
1.48
Technicals
50-Day MA
0.3144
200-Day MA
0.3325
52 Week High
0.5
52 Week Low
0.25
About IGC
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease in India, the United States, and Colombia.
Employees
70
Headquarters
Potomac, MD
CEO
Mr. Ram Mukunda
Latest News
Massive 69.4% Surge for IGC Pharma in After-Hours Trading: Here's Why - Benzinga
6 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg